OPS: 3-800 Native magnetic resonance imaging of the skull
Conditions
Interventions
Group 1: Patient who had cheek Augmentation with Belotero® Volume (4-7 patients). 1 MRI before injection, MRIs after 14 day, 6 months and 12 months.
Group 2: Patient who had cheek Augmentation with
Sponsors
Ästhetische Dermatologie, Universitätsklinikum Düsseldorf
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: healthy subjects with the capacity to give consent, aged 18 years and over, who give their written and verbal consent to participate of their own free will planned cheek augmentation in domo with the above mentioned 3 brands
Exclusion criteria
Exclusion criteria: - Claustrophobia - Artificial heart valve - Cardiac pacemaker - Cochlear implant - all other metallic implants - Non-removable metal in the body - Age under 18 years - lack of written consent - Pregnancy - Additional MRI exclusion criteria (to be reviewed by the study physician) - active infection in the treatment area - known allergy to the ingredients of the hyaluronan preparations - intake of blood thinning medication - intake (e.g. Aspirin ®) in the last 48 hours before treatment - pre-treatment with volume filler in the facial area to be injected
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The studys goal is to evaluate the dynamic of hyaluronic acid fillers over 12 months by MRI and a comparison between three different producs. last MRI after 12 months | — |
Countries
Germany
Contacts
Public ContactParnian Firouzi-Memarpuri
Ästhetische Dermatologie, Universitätsklinikum Düsseldorf
Outcome results
None listed